CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,782,438 | -4.5% | 94,448 | +5.8% | 0.53% | -6.9% |
| Q2 2023 | $2,912,183 | -7.6% | 89,276 | -0.3% | 0.57% | -11.0% |
| Q1 2023 | $3,151,124 | -25.9% | 89,546 | -3.5% | 0.64% | -26.2% |
| Q4 2022 | $4,253,608 | -7.7% | 92,833 | -2.4% | 0.86% | -9.1% |
| Q3 2022 | $4,607,000 | -15.7% | 95,090 | -31.7% | 0.95% | -11.7% |
| Q2 2022 | $5,468,000 | +57.1% | 139,176 | +47.2% | 1.07% | +119.2% |
| Q1 2022 | $3,481,000 | -9.7% | 94,556 | +11.8% | 0.49% | -8.8% |
| Q4 2021 | $3,854,000 | +7.7% | 84,549 | -15.6% | 0.54% | +18.3% |
| Q3 2021 | $3,580,000 | – | 100,180 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |